News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Clarus Lifesciences III, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/01/2022 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Imago BioSciences, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 04/01/2022 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 7.2% stake in Imago BioSciences, Inc. |
| 01/12/2022 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 5% stake in ESSA PHARMA INC. |
| 07/30/2021 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 10.5% stake in Imago BioSciences, Inc. |
| 07/20/2021 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Imago BioSciences, Inc.|
Txns:
| Converted 1,872,217 shares
@ $0
Converted 1,155,689 shares
@ $0
Converted 197,131 shares
@ $0
Bought 150,000 shares
@ $16, valued at
$2.4M
Converted 1,872,217 convertible preferred
@ $0
Converted 1,155,689 convertible preferred
@ $0
Converted 197,131 convertible preferred
@ $0 |
|
| 07/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/14/2021 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Disposed of 2,700,000 shares
@ $0 |
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/22/2020 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Converted 3,446,711 shares
@ $0
Converted 2,361,198 shares
@ $0
Converted 659,116 shares
@ $0
Converted 261,318 shares
@ $0
Converted 907,378 shares
@ $0
Converted 164,832 shares
@ $0
Converted 7,375,799 options to buy
@ $0
Converted 5,052,852 options to buy
@ $0
Converted 1,410,477 options to buy
@ $0
Converted 559,208 options to buy
@ $0
Converted 1,941,748 options to buy
@ $0 |
|
| 10/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/01/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/09/2020 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 4.9% stake in Entasis Therapeutics Holdings Inc. |
| 05/01/2020 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 11.1% stake in Entasis Therapeutics Holdings Inc. |
| 09/06/2019 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 16.7% stake in ESSA PHARMA INC. |
| 08/05/2019 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 0% stake in AVROBIO, Inc. |
| 05/22/2019 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Disposed of 1,481,163 shares
@ $0 |
|
| 10/12/2018 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 8.9% stake in Gritstone Oncology, Inc. |
| 10/09/2018 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 12.4% stake in Entasis Therapeutics Holdings Inc. |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Bought 333,333 shares
@ $15, valued at
$5M
Converted 2,234,112 shares
@ $0
Converted 1,565,216 convertible preferred
@ $0
Converted 668,896 convertible preferred
@ $0 |
|
| 09/27/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/25/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 07/12/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/05/2018 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 12.8% stake in Avrobio, Inc. |
| 07/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Converted 938,489 shares
@ $0
Converted 755,780 shares
@ $0
Converted 1,922,682 shares
@ $0
Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0
Converted 755,780 preferred shares
@ $0
Converted 1,922,682 preferred shares
@ $0 |
|
| 06/27/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Forty Seven, Inc. |
| 06/25/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Converted 2,283,434 shares
@ $0
Converted 678,891 shares
@ $0
Converted 9,435,150 preferred shares
@ $0
Converted 2,805,179 preferred shares
@ $0 |
|
| 06/20/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on AVROBIO, Inc. |
|
|
|